BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023

  Evofem Biosciences, Inc. (OTCQB: EVFMD) today announced strong preliminary results for the first quarter of 2023, including robust growth in net product sales of its hormone-free prescription contraceptive gel, Phexxi® (lactic acid, citric acid and potassium bitartrate).

  June 1, 2023

   · 

  3 min read
• Biotech Bay

  Seer Launches the Proteograph XT Assay Kit: Allowing Labs to Easily Expand Their View of the Proteome and Scale Their Studies

  Seer Inc., a life sciences company commercializing a disruptive new platform for proteomics, announced the launch of the Proteograph XT Assay Kit, the latest proteomics assay workflow for the Proteograph Product Suite.

  June 1, 2023

   · 

  5 min read
• Business

  Alkermes Appoints Caroline J. Loew, Ph.D., as Chief Executive Officer Designate of Mural Oncology plc

  Alkermes plc announced that Caroline J. Loew, Ph.D., has been appointed as the chief executive officer designate of Mural Oncology plc, the new independent public company to be established upon the planned separation of Alkermes’ oncology business.

  June 1, 2023

   · 

  8 min read
• Business

  Nuvation Bio Announces Formation of Oncology-Focused Scientific Advisory Board

  Nuvation Bio Inc., a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, announced the formation of a Scientific Advisory Board.

  June 1, 2023

   · 

  8 min read